from Reuters: Health News https://reut.rs/2UJg6yv
Friday, 26 April 2019
FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc's cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.
from Reuters: Health News https://reut.rs/2UJg6yv
from Reuters: Health News https://reut.rs/2UJg6yv
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment